Comprehensive Analysis of CRIP1 in Patients with Ovarian Cancer, including ceRNA Network, Immune-Infiltration Pattern, and Clinical Benefit

Figure 4

Prognostic value of CRIP1 in OC Patients. (a) OS: overall survival; (b) DSS: disease-specific survival. (c) PFI: progress-free interval. (d) ROC analysis for OS. Survival analysis of clinical subgroups, including (e) FIGO stage, (f) age, (g) histologic grade, (h) venous invasion, (i) lymphatic invasion, and (j) primary therapy outcome.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)